cigna glp-1 reaches new deal on Eli Lilly and Novo Nordisk weight loss drugs Perspectives from employers on the

Ceramides and Phospholipids Are Downregulated with Liraglutide Treatment: Results from the LiraFlame Randomized Controlled Trial

Worsening diabetic retinopathy: Rapid improvement in blood sugar can temporarily worsen eye damage in diabetic patients

By including all English-language studies on muscle mass loss during GLP-1RA therapy in T2D and obesity from major scientific databases and clinical trial registries, this narrative review synthesizes the current knowledge on the epidemiology and mechanisms of muscle loss in diabetes and obesity, with a focus on the impact of GLP-1RAs therapy

Zhong J, Rao X, Deiuliis J, Braunstein Z, Narula V, Hazey J, et al

[DOI] [PubMed] [Google Scholar] 281.Cohen F., Mills D., Chesak J

Indeed, early preclinical studies demonstrated attenuation of renal TGF- expression in association with reduced expression of collagens within the kidney after GLP-1 receptor agonist therapy (62)